Marlene Wullt

affiliated with the university
More filtering options
  1. 2019
  2. Humoral response to Clostridium difficile in inflammatory bowel disease, including correlation with immunomodulatory treatment

    Gunnel Henriksson, Bredberg, J., Marlene Wullt, Lyrenäs, E., Hindorf, U., Ohlsson, B. & Olof Grip, 2019 Apr, In : JGH Open. 3, 2, p. 154-158 5 p.

    Research output: Contribution to journalArticle

  3. 2015
  4. 2014
  5. High frequency of myeloid-derived suppressor cells in sepsis patients, with the granulocytic subtype dominating in Gram-positive cases

    Janols, H., C. Bergenfelz, Allaoui, R., Larsson, A. M., L. Rydén, Björnsson, S., S. Janciauskiene, M. Wullt, A. Bredberg & K. Leandersson, 2014, In : Critical Care. 18, Suppl 2, p. 2 P3.

    Research output: Contribution to journalPublished meeting abstract

  6. 2013
  7. Ribotyping of Clostridium difficile strains associated with nosocomial transmission and relapses in a Swedish County

    Magnusson, C., Marlene Wullt, Lofgren, S., Iveroth, P., Akerlund, T. & Matussek, A., 2013, In : APMIS : acta pathologica, microbiologica, et immunologica Scandinavica. 121, 2, p. 153-157

    Research output: Contribution to journalArticle

  8. 2012
  9. IgG Antibody Response to Toxins A and B in Patients with Clostridium difficile Infection.

    Marlene Wullt, Norén, T., Ljungh, A. & Akerlund, T., 2012, In : Clinical and Vaccine Immunology. 19, 9, p. 1552-1554

    Research output: Contribution to journalArticle

  10. 2011
  11. Städning och ytdesinfektion som mått på god vårdhygien: Observationer från en sjukhusbädd.

    Marlene Wullt, 2011, In : Läkartidningen. 108, 10, p. 520-521

    Research output: Contribution to journalArticle

  12. 2010
  13. Reducing Blood Culture Contamination by a Simple Informational Intervention

    Adam Roth, Wiklund, A. E., Palsson, A. S., Eva Melander, Marlene Wullt, Cronqvist, J., Mats Walder & Erik Sturegård, 2010, In : Journal of Clinical Microbiology. 48, 12, p. 4552-4558

    Research output: Contribution to journalArticle

  14. 2008
  15. Increased sporulation rate of epidemic clostridium difficile type 027/NAP1

    Åkerlund, T., Persson, I., Unemo, M., Noren, T., Svenungsson, B., Marlene Wullt & Burman, L. G., 2008, In : Journal of Clinical Microbiology. 46, 4, p. 1530-1533

    Research output: Contribution to journalArticle

  16. 2007
  17. Mutations in fusA associated with posttherapy fusidic acid resistance in Clostridium difficile

    Noren, T., Akerlund, T., Marlene Wullt, Burman, L. G. & Unemo, M., 2007, In : Antimicrobial Agents and Chemotherapy. 51, 5, p. 1840-1843

    Research output: Contribution to journalArticle

  18. 2006
  19. Frequent emergence of resistance in Clostridium difficile during treatment of C-difficile-associated diarrhea with Fusidic acid

    Noren, T., Marlene Wullt, Akerlund, T., Back, E., Inga Odenholt & Burman, L. G., 2006, In : Antimicrobial Agents and Chemotherapy. 50, 9, p. 3028-3032

    Research output: Contribution to journalArticle

  20. 2004
  21. 2003
  22. Clostridium difficile-associated diarrhoea - aspects of hospital epidemiology and treatment

    Marlene Wullt, 2003, Marlene Wullt, Department of Infectious Diseases, University Hospital MAS, SE-205 02 Malmö, Sweden,. 120 p.

    Research output: ThesisDoctoral Thesis (compilation)

  23. Comparison of AP-PCR typing and PCR-ribotyping for estimation of nosocomial transmission of Clostridium difficile.

    Marlene Wullt, Burman, L. G., Martin Laurell & Akerlund, T., 2003, In : Journal of Hospital Infection. 55, 2, p. 124-130

    Research output: Contribution to journalArticle